PubMed

Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

Diabetes Obes Metab. 2009 Oct;11(10):966-77. Epub 2009 Jun 25.PMID: 19558610 [PubMed - in process]Related articles

Rapid decline in 51Cr-EDTA measured renal function during the first weeks following lung transplantation.

Hornum M, Iversen M, Steffensen I, Hovind P, Carlsen J, Andersen LW, Steinbrüchel DA, Feldt-Rasmussen B.

Am J Transplant. 2009 Jun;9(6):1420-6. Epub 2009 May 13.PMID: 19459826 [PubMed - in process]Related articles

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study.

Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH.

Diabetes. 2009 Jul;58(7):1668-71. Epub 2009 May 1.PMID: 19411615 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

PLoS One. 2008;3(10):e3363. Epub 2008 Oct 9.PMID: 18852875 [PubMed - indexed for MEDLINE]Related articlesFree article

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.

Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk CG, Tarnow L, Parving HH.

Scand J Clin Lab Invest. 2008;68(8):731-8.PMID: 18609080 [PubMed - indexed for MEDLINE]Related articles

Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation.

Hornum M, Burton CM, Iversen M, Hovind P, Hilsted L, Feldt-Rasmussen B.

Nephrol Dial Transplant. 2007 Dec;22(12):3616-22. Epub 2007 Aug 3.PMID: 17675330 [PubMed - indexed for MEDLINE]Related articles

An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes.

Hovind P, Lamberts S, Hop W, Deinum J, Tarnow L, Parving HH, Janssen JA.

Eur J Endocrinol. 2007 Jan;156(1):83-90.PMID: 17218729 [PubMed - indexed for MEDLINE]Related articlesFree article

Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy.

Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk C, Tarnow L, Parving HH.

Diabetes. 2006 Dec;55(12):3550-5.PMID: 17130503 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.

Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH.

Diabetologia. 2006 Oct;49(10):2256-62. Epub 2006 Aug 26.PMID: 16937127 [PubMed - indexed for MEDLINE]Related articles

Initiation, progression and remission of diabetic nephropathy.

Hovind P.

Dan Med Bull. 2005 Dec;52(4):119-42. Review. No abstract available. PMID: 16764047 [PubMed - indexed for MEDLINE]Related articles

Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.

Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article

Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.

Rossing K, Christensen PK, Hovind P, Parving HH.

Diabetologia. 2005 Nov;48(11):2241-7. Epub 2005 Sep 17.PMID: 16170513 [PubMed - indexed for MEDLINE]Related articles

Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.

Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK.

Diabetes Care. 2005 Aug;28(8):1988-94.PMID: 16043743 [PubMed - indexed for MEDLINE]Related articlesFree article

Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study.

Hovind P, Hansen TK, Tarnow L, Thiel S, Steffensen R, Flyvbjerg A, Parving HH.

Diabetes. 2005 May;54(5):1523-7.PMID: 15855341 [PubMed - indexed for MEDLINE]Related articlesFree article

Telmisartan vs. enalapril in type 2 diabetes.

Parving HH, Hovind P, Rossing P.

N Engl J Med. 2005 Feb 24;352(8):835-6; author reply 835-6. No abstract available. PMID: 15736292 [PubMed - indexed for MEDLINE]Related articles

[Risk factors for the development of microalbuminuria in type 1 diabetes: an incidence cohort study--a secondary publication]

Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH.

Ugeskr Laeger. 2005 Jan 3;167(1):57-60. Danish. No abstract available. PMID: 15675170 [PubMed - indexed for MEDLINE]Related articles

Progression of nephropathy in type 2 diabetic patients.

Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.

Kidney Int. 2004 Oct;66(4):1596-605.PMID: 15458456 [PubMed - indexed for MEDLINE]Related articles

Remission and regression of diabetic nephropathy.

Hovind P, Tarnow L, Parving HH.

Curr Hypertens Rep. 2004 Oct;6(5):377-82. Review.PMID: 15341691 [PubMed - indexed for MEDLINE]Related articles

Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.

Hovind P, Tarnow L, Rossing P, Carstensen B, Parving HH.

Kidney Int. 2004 Sep;66(3):1180-6.PMID: 15327415 [PubMed - indexed for MEDLINE]Related articles

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.

Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH.

BMJ. 2004 May 8;328(7448):1105. Epub 2004 Apr 19.PMID: 15096438 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.

Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, Hovind P, Rossing P, Tarnow L.

Semin Nephrol. 2004 Mar;24(2):147-57. Review.PMID: 15017527 [PubMed - indexed for MEDLINE]Related articles

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.

Jacobsen P, Tarnow L, Carstensen B, Hovind P, Poirier O, Parving HH.

J Am Soc Nephrol. 2003 Nov;14(11):2843-50.PMID: 14569094 [PubMed - indexed for MEDLINE]Related articlesFree article

Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH.

Diabetes Care. 2003 Apr;26(4):1258-64.PMID: 12663607 [PubMed - indexed for MEDLINE]Related articlesFree article

Smoking and progression of diabetic nephropathy in type 1 diabetes.

Hovind P, Rossing P, Tarnow L, Parving HH.

Diabetes Care. 2003 Mar;26(3):911-6.PMID: 12610058 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria study.

Rossing K, Christensen PK, Andersen S, Hovind P, Hansen HP, Parving HH; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study.

Diabetes Care. 2003 Mar;26(3):569-74.PMID: 12610003 [PubMed - indexed for MEDLINE]Related articlesFree article

Birth weight--a risk factor for progression in diabetic nephropathy?

Jacobsen P, Rossing P, Tarnow L, Hovind P, Parving HH.

J Intern Med. 2003 Mar;253(3):343-50.PMID: 12603502 [PubMed - indexed for MEDLINE]Related articles

Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy.

Parving HH, Hovind P.

Curr Hypertens Rep. 2002 Oct;4(5):387-93. Review.PMID: 12217258 [PubMed - indexed for MEDLINE]Related articles

Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy.

Hansen HP, Hovind P, Jensen BR, Parving HH.

Kidney Int. 2002 Jan;61(1):163-8. Erratum in: Kidney Int 2002 Aug;62(2):731. PMID: 11786097 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.

Hovind P, Tarnow L, Rossing P, Teerlink T, Stehouwer CD, Emeis JJ, Parving HH.

Am J Kidney Dis. 2001 Dec;38(6):1376-80.PMID: 11728978 [PubMed - indexed for MEDLINE]Related articles

Remission of nephrotic-range albuminuria in type 1 diabetic patients.

Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH.

Diabetes Care. 2001 Nov;24(11):1972-7.PMID: 11679467 [PubMed - indexed for MEDLINE]Related articlesFree article

Evolving strategies for renoprotection: diabetic nephropathy.

Parving HH, Hovind P, Rossing K, Andersen S.

Curr Opin Nephrol Hypertens. 2001 Jul;10(4):515-22. Review.PMID: 11458033 [PubMed - indexed for MEDLINE]Related articles

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.

Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.

Kidney Int. 2001 Jul;60(1):277-83.PMID: 11422762 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression of diabetic nephropathy.

Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.

Kidney Int. 2001 Feb;59(2):702-9.PMID: 11168952 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

Hovind P, Tarnow L, Oestergaard PB, Parving HH.

Kidney Int Suppl. 2000 Apr;75:S56-61.PMID: 10828763 [PubMed - indexed for MEDLINE]Related articles

Spleen emptying and venous hematocrit in humans during exercise.

Laub M, Hvid-Jacobsen K, Hovind P, Kanstrup IL, Christensen NJ, Nielsen SL.

J Appl Physiol. 1993 Mar;74(3):1024-6.PMID: 8387068 [PubMed - indexed for MEDLINE]Related articles